Fund Size
(2.73% of Investment in Category)
|
Expense Ratio
(0.64% Category average)
|
Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
---|---|---|---|---|---|---|
1 Week | 05-Sep-25 | 10168.20 | 1.68% | - | 1.41% | 7/33 |
1 Month | 12-Aug-25 | 10245.10 | 2.45% | - | 3.32% | 27/32 |
3 Month | 12-Jun-25 | 10140.90 | 1.41% | - | 2.45% | 24/32 |
6 Month | 12-Mar-25 | 11827.10 | 18.27% | - | 17.45% | 14/31 |
YTD | 01-Jan-25 | 10169.20 | 1.69% | - | 2.29% | 16/30 |
1 Year | 12-Sep-24 | 9775.60 | -2.24% | -2.24% | -0.64% | 22/27 |
2 Year | 12-Sep-23 | 14328.90 | 43.29% | 19.67% | 19.52% | 12/22 |
3 Year | 12-Sep-22 | 17386.40 | 73.86% | 20.23% | 19.25% | 7/15 |
5 Year | 11-Sep-20 | 33544.00 | 235.44% | 27.35% | 25.13% | 2/9 |
Since Inception | 11-May-17 | 41069.60 | 310.70% | 18.45% | 16.57% | 16/33 |
Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
---|---|---|---|---|---|
1 Year | 12-Sep-24 | 12000 | 12604.03 | 5.03 % | 9.43 % |
2 Year | 12-Sep-23 | 24000 | 27360.17 | 14 % | 13.12 % |
3 Year | 12-Sep-22 | 36000 | 48008.4 | 33.36 % | 19.58 % |
5 Year | 11-Sep-20 | 60000 | 101371.9 | 68.95 % | 21.08 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
---|---|---|---|---|---|---|---|---|
ICICI Bank Ltd. | Private sector bank | 1961.1 | 3.49% | -0.14% | 3.63% (Jul 2025) | 0% (Sep 2024) | 14.03 L | 0.00 |
Divis Laboratories Ltd. | Pharmaceuticals | 1870.1 | 3.33% | -0.18% | 3.66% (Feb 2025) | 1.02% (Sep 2024) | 3.05 L | 0.00 |
Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 1798.9 | 3.20% | -0.28% | 3.48% (Jul 2025) | 0% (Sep 2024) | 9.35 L | 0.00 |
Laurus Labs Ltd. | Pharmaceuticals | 1717.1 | 3.05% | -0.37% | 3.42% (Jul 2025) | 0% (Sep 2024) | 20.04 L | -2.36 L |
HDFC Bank Ltd. | Private sector bank | 1693.9 | 3.01% | -0.13% | 8.06% (Feb 2025) | 3.01% (Aug 2025) | 17.80 L | 8.90 L |
Ultratech Cement Ltd. | Cement & cement products | 1580 | 2.81% | 0.14% | 2.81% (Aug 2025) | 0% (Sep 2024) | 1.25 L | 0.00 |
Indus Towers Ltd. | Telecom - infrastructure | 1520.3 | 2.70% | -0.15% | 3.6% (Apr 2025) | 0% (Sep 2024) | 44.90 L | 0.00 |
Reliance Industries Ltd. | Refineries & marketing | 1391.1 | 2.47% | -0.02% | 4.43% (Jan 2025) | 2.47% (Aug 2025) | 10.25 L | 0.00 |
Maruti Suzuki India Ltd. | Passenger cars & utility vehicles | 1116.7 | 1.99% | 0.33% | 1.99% (Aug 2025) | 0% (Sep 2024) | 75.50 k | 0.00 |
Mphasis Ltd. | Computers - software & consulting | 1101.3 | 1.96% | 0.04% | 1.96% (Aug 2025) | 0% (Sep 2024) | 3.95 L | 0.00 |
Name | Type of Instrument | Weight (%) |
---|---|---|
TREPS | TREPS | 4.35% |
Net Receivables | Net Receivables | 0.83% |
Ratios calculated on daily returns for last 3 years (Updated as on 29th August, 2025)
Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
---|---|---|---|---|---|---|---|
Motilal Oswal Multi Cap Fund - Direct Plan - Growth | NA | 4285.22 | 7.26 | 6.22 | 18.14 | 15.59 | 0.00 |
WhiteOak Capital Multi Cap Fund - Direct Plan - Growth | NA | 2261.56 | 2.75 | 3.63 | 19.78 | 6.00 | 0.00 |
Mirae Asset Multicap Fund - Direct Plan - Growth | NA | 3972.98 | 3.23 | 2.66 | 20.22 | 2.86 | 0.00 |
SBI Multicap Fund - Direct Plan - Growth | 4 | 22424.23 | 2.03 | 1.79 | 14.14 | 2.52 | 16.58 |
Canara Robeco Multi Cap Fund - Direct Plan - Growth | NA | 4554.81 | 2.65 | 2.23 | 18.59 | 1.27 | 0.00 |
Nippon India Multicap Fund - Direct Plan - Growth | 4 | 46215.71 | 3.08 | 2.66 | 19.10 | 0.94 | 23.21 |
Franklin India Multi Cap Fund - Direct Plan - Growth | NA | 4931.46 | 4.96 | 4.62 | 19.66 | 0.91 | 0.00 |
Axis Multicap Fund - Direct Plan - Growth | 5 | 8328.62 | 3.44 | 3.16 | 16.98 | 0.91 | 22.71 |
Edelweiss Recently Listed IPO Fund - Direct Plan - Growth | NA | 924.38 | 5.68 | 8.74 | 22.47 | 0.90 | 15.78 |
Sundaram Multi Cap Fund - Direct Plan - Growth | 2 | 2810.27 | 2.87 | 3.23 | 17.42 | 0.41 | 16.95 |
Out of 25 mutual fund schemes offered by this AMC, 5 is/are ranked 4 * , 4 is/are ranked 3 * , 1 is/are ranked 2 * , 3 is/are ranked 1 * , and 12 schemes are not ranked. See more about AMC